These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1655591)

  • 1. Androgen associated hepatocellular carcinoma with an aggressive course.
    Gleeson D; Newbould MJ; Taylor P; McMahon RF; Leahy BC; Warnes TW
    Gut; 1991 Sep; 32(9):1084-6. PubMed ID: 1655591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in association with androgen therapy.
    Goodman MA; Laden AM
    Med J Aust; 1977 Feb; 1(7):220-1. PubMed ID: 191737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival with tumor regression in androgen-induced liver tumors.
    McCaughan GW; Bilous MJ; Gallagher ND
    Cancer; 1985 Dec; 56(11):2622-6. PubMed ID: 2996742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen related primary hepatic tumors in non-Fanconi patients.
    Westaby D; Portmann B; Williams R
    Cancer; 1983 May; 51(10):1947-52. PubMed ID: 6299502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.
    Velazquez I; Alter BP
    Am J Hematol; 2004 Nov; 77(3):257-67. PubMed ID: 15495253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years.
    Boyd PR; Mark GJ
    Cancer; 1977 Oct; 40(4):1765-70. PubMed ID: 198106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens and hepatocellular carcinoma.
    Ziegenfuss J; Carabasi R
    Lancet; 1973 Feb; 1(7797):262. PubMed ID: 4119402
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.
    Johnson FL; Lerner KG; Siegel M; Feagler JR; Majerus PW; Hartmann JR; Thomas ED
    Lancet; 1972 Dec; 2(7790):1273-6. PubMed ID: 4117807
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic complications of androgen therapy.
    Murray-Lyon IM; Westaby D; Paradinas F
    Gastroenterology; 1977 Dec; 73(6):1461. PubMed ID: 199526
    [No Abstract]   [Full Text] [Related]  

  • 10. Methyltestosterone-induced liver-cell tumours.
    Cocks JR
    Med J Aust; 1981 Nov; 2(11):617-9. PubMed ID: 6278274
    [No Abstract]   [Full Text] [Related]  

  • 11. Androgenic-anabolic steroid therapy and hepatocellular carcinoma.
    Henderson JT; Richmond J; Sumerling MD
    Lancet; 1973 Apr; 1(7809):934. PubMed ID: 4123858
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful management of an androgen-induced hepatic adenoma by embolisation of the hepatic artery.
    Lewis JL; Irving JD; Beswick D; Mason RC
    J R Coll Surg Edinb; 1986 Oct; 31(5):315-6. PubMed ID: 3025436
    [No Abstract]   [Full Text] [Related]  

  • 13. Androgen-induced hepatoma.
    Farrell GC; Joshua DE; Uren RF; Baird PJ; Perkins KW; Kronenberg H
    Lancet; 1975 Feb; 1(7904):430-2. PubMed ID: 48615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous rupture of a liver cell adenoma after long term methyltestosterone: report of a case successfully treated by emergency right hepatic lobectomy.
    Bird D; Vowles K; Anthony PP
    Br J Surg; 1979 Mar; 66(3):212-3. PubMed ID: 218669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumors of the liver secondary to androgen therapy. Apropos of 2 cases in children].
    Frémond B; Jouan H; Sameh AH; Le Gall E; Bergeron C; Manac'h A; Gruel Y; Babut JM
    Chir Pediatr; 1987; 28(2):97-101. PubMed ID: 3040281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myeloproliferative disorder and hepatocellular adenoma following androgen treatment of a patient with aplastic anemia (author's transl)].
    Tsunematsu Y; Sasaki M; Koide T; Shimizu K
    Rinsho Ketsueki; 1978 Dec; 19(12):1699-707. PubMed ID: 216824
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver pathology associated with anabolic androgenic steroids].
    Søe KL; Søe M; Gluud CN
    Ugeskr Laeger; 1994 Apr; 156(17):2585-8. PubMed ID: 8016966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lesions in patients treated with synthetic anabolic steriods.
    Sweeney EC; Evans DJ
    J Clin Pathol; 1976 Jul; 29(7):626-33. PubMed ID: 185239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular adenoma after oral contraception].
    Olesen LL; Vyberg M; Kruse V; Møller J; Christensen H
    Ugeskr Laeger; 1992 Oct; 154(41):2820-3. PubMed ID: 1329298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is methyltestosterone no longer used therapeutically?].
    Nieschlag E
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1123-5. PubMed ID: 7261937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.